:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Paidi, Murali Krishna, Biradar, Shivaleela, Keshava Prasad, T S
Format:	Artículo científico
Language:	en
Published:	In silico pharmacology 2026
Online Access:	https://pubmed.ncbi.nlm.nih.gov/41613639/
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS‐CoV‐2 nucleocapsid antigen in plasma of children hospitalized for COVID‐19 or with incidental detection of SARS‐CoV‐2 infection
by: Nicolas Capelli, et al.
Published: (2024)

A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity
by: Guoguo Ye, et al.
Published: (2024)

SARS ‐ CoV ‐2 nucleocapsid protein variants have differential RNA chaperone activity
by: Sabrina Babl, et al.
Published: (2025)

An exhaustive computational bioassessment of plant‐derived terpenoids as potential SARS‐CoV‐2 inhibitors
by: Arunkumar Radhakrishnan, et al.
Published: (2026)

Ensemble docking based virtual screening of SARS‐CoV‐2 main protease inhibitors
by: Anastasia D. Fomina, et al.
Published: (2024)

Improved fluorescence‐based assay for rapid screening and evaluation of SARS‐CoV‐2 main protease inhibitors
by: Rui Zhang, et al.
Published: (2024)

Interaction and co‐phase separation of SARS ‐ CoV ‐2 nucleocapsid protein and human hnRNPA1 and its implications for viral life cycle
by: Parul Gupta, et al.
Published: (2026)

Intrinsic factors behind long COVID: IV. Hypothetical roles of the SARS‐CoV‐2 nucleocapsid protein and its liquid–liquid phase separation
by: Ahmed Eltayeb, et al.
Published: (2024)

Identification of SARS-CoV-2 3CLpro inhibitors from marine actinomycetes through integrated phylogeny-based metabolomics with functional screening and bioinformatic analysis.
by: Dalisay, Doralyn S, et al.
Published: (2025)

Pharmacological reprogramming of plitidepsin as a SARS-CoV-2 inhibitor.
by: Jimeno, Jose, et al.
Published: (2025)

Phthalimide derivatives as a new class of papain‐like protease inhibitors in SARS‐CoV‐2
by: Thomas Fischer, et al.
Published: (2024)

Structural Immunology of SARS‐CoV‐2
by: Meng Yuan, et al.
Published: (2024)

NMR screening of low molecular weight inhibitors targeting the papain‐like protease (PLPro) of SARS‐CoV‐2
by: Dennis J. Pyper, et al.
Published: (2025)

Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease
by: Maryelle A. G. de Carvalho, et al.
Published: (2024)

Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors
by: Lucile Brier, et al.
Published: (2024)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel
Published: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Predicting potential SARS-CoV-2 spillover and spillback in animals
by: Tan, Zi Hian, et al.
Published: (2024)

Psoralidin acts as a dual protease inhibitor against PL pro and M pro of SARS ‐ CoV ‐2
by: Aditya Trivedi, et al.
Published: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
by: Monica Rosas‐Lemus, et al.
Published: (2025)

Pandemia por SARS-CoV-2
by: Erina Petrera
Published: (2020)

SARS-CoV-2 and Saliva: an update
by: Muniz, Isis de Araújo Ferreira, et al.
Published: (2020)

Demografía y SARS-CoV-2
by: Manuel Ordorica Mellado
Published: (2021)

Optimization of a DNA‐launched SARS‐CoV‐2 replicon with RNA splicing inhibitor Isoginkgetin
by: Hu Zhang, et al.
Published: (2024)

Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS ‐ CoV and SARS ‐ CoV ‐2
by: Alexandre Hassanin, et al.
Published: (2024)

SARS-CoV-2 and ACE2 nexus
by: Arifuddin, Mehnaaz Sameera
Published: (2020)

Real-time PCR-based SARS-CoV-2 detection
by: Mesa, José Francisco Cancino, et al.
Published: (2020)

Real-time PCR-based SARS-CoV-2 detection
by: Mesa, José Francisco Cancino, et al.
Published: (2020)

Guidelines in Wastewater-based Epidemiology of SARS-CoV-2 with Diagnosis
by: Fatima, Madiha, et al.
Published: (2023)

Unbelievable $O(L^{1.5})$ worst case computational complexity achieved by $spdspds$ algorithm for linear programming problem
by: Halemane, Keshava Prasad
Published: (2014)

Spumigins produced by Nodularia spumigena are natural serine protease inhibitors with anti-SARS-CoV-2 activity.
by: Milewska, Aleksandra, et al.
Published: (2026)

SARS-CoV-2 y aparato digestivo
by: Iván Carabaño Aguado
Published: (2020)

SARS-CoV-2: a clinical update
by: da Silveira Cespedes, Mateus, et al.
Published: (2020)

COVID-19 y SARS-CoV-2
by: Alfredo Pinzón-Junca
Published: (2020)

Non‐Neutralising Antibodies and T Cell Responses to SARS ‐ CoV ‐2 Detected in Unvaccinated SARS ‐ CoV ‐2‐Naive Spanish Adolescents
by: Hector F. Pelaez‐Prestel, et al.
Published: (2025)

Antimicrobial peptides and other potential biomarkers of critical illness in SARS‐CoV‐2 patients with acute kidney injury. AMPAKI‐CoV study
by: Lucas Ferreira Theotonio dos Santos, et al.
Published: (2024)

SARS‐CoV‐2 Genome and S2 Spike Protein: IRF‐Driven Interferon Regulation and Host Cell Responses
by: Ekta Singh, et al.
Published: (2025)

Indirect effects of the SARS CoV-2 pandemic on the prevalence of breastfeeding: Modeling its impact
by: Álvaro Jácome
Published: (2021)

Deubiquitinase inhibitors: Targeting SARS ‐ CoV ‐2 papain‐like protease with antiviral efficacy in a murine model
by: Shweta Choudhary, et al.
Published: (2026)